Clinical Trial Update: Ghrelin and Beta Cell Function in Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating ghrelin's effect on beta cell function in Type 2 Diabetes Mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ghrelin (ghrelin)

Snippet

Sponsor: Jenny Tong, MD, MPH | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: WITHDRAWN